publication date: Jan. 16, 2016

Leonard Zon Receives NCI Alfred G. Knudson Cancer Genetics Award


LEONARD ZON received the 20th annual Alfred G. Knudson Award in Cancer Genetics from the NCI.

Zon is director of the Stem Cell Program at Boston Children’s Hospital and the Grousbeck Professor of Pediatrics at Harvard Medical School,

The award, named for the physician and geneticist who helped revolutionize the understanding of the genetic basis of cancer, is presented annually to a scientist who has made outstanding research contributions to the field of cancer genetics. Zon delivered his award lecture, “Modulating Cell Fate for Cancer Therapeutics: Insights from Embryonic Development,” at the annual NCI Intramural Scientific Investigators Retreat in Maryland.

In addition to his positions at Boston Children’s Hospital and Harvard Medical School, Zon is a Howard Hughes Medical Institute investigator, professor of stem cell and regenerative biology at Harvard University, and an associate member of the Broad Institute of Harvard and MIT.

He pioneered the use of the zebrafish for the study of human blood formation and disease, including many types of cancer. Zon’s translational zebrafish research led to the discovery and development of two novel therapeutics that are now being evaluated in clinical trials of patients with leukemia and melanoma. His research is largely focused on better understanding the genetics of blood diseases, melanoma, and other cancers.

Zon founded and is past president of the International Society of Stem Cell Research and former chairman and a member of the executive committee of the Harvard Stem Cell Institute. He is also a member of the … Continue reading 42-02 Leonard Zon Receives NCI Alfred G. Knudson Cancer Genetics Award

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.